SCHEMBL20140658

SCHEMBL20140658

C[C@H]1CN(c2nccc3cn[nH]c23)CCN1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 7/20 0.50
ROCK1 Q13464 4/20 0.43
PRKCQ Q04759 3/20 0.42
PRKCD Q05655 1/20 0.42
KIT P10721 1/20 0.42
HRH4 Q9H3N8 2/20 0.42
MAPK13 O15264 1/20 0.41
MAPK12 P53778 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41
ACVR1 Q04771 3/20 0.39
PRKCI P41743 1/20 0.38
CDK1 P06493 2/20 0.37
CDK4 P11802 2/20 0.37
CCNB1 P14635 2/20 0.37
CCNA2 P20248 2/20 0.37
CCND1 P24385 2/20 0.37
CDK2 P24941 2/20 0.37
CCNA1 P78396 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20140662 1.00 ROCK2 (0.50) ROCK2ROCK1PRKCQPRKCDKIT
SCHEMBL20157192 0.81 KIT (0.42) ROCK2ROCK1PRKCQPRKCDKIT
SCHEMBL20157193 0.81 KIT (0.42) ROCK2ROCK1PRKCQPRKCDKIT
SCHEMBL20141025 0.80 HTR2C (0.56) ROCK2ROCK1
SCHEMBL20141437 0.78 HTR1A (0.44) ROCK2ROCK1PRKCQPRKCDPRKCI
SCHEMBL20141435 0.78 HTR1A (0.44) ROCK2ROCK1PRKCQPRKCDPRKCI
SCHEMBL6281370 0.77 HTR2C (0.65) PRKCQPRKCDKITHRH4
SCHEMBL6271843 0.77 HTR2C (0.65) PRKCQPRKCDKITHRH4
SCHEMBL3683893 0.76 HTR2C (0.47) ROCK2PRKCQPRKCDKITHRH4
SCHEMBL3683532 0.75 HDAC2 (0.44) ROCK2PRKCQPRKCDKITHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed